OBJECTIVES: The aim of this study was to investigate the role of the interleukin-18 +105A/C and interleukin-10 -1082A/G germline polymorphisms in the development and outcome of differentiated thyroid carcinoma associated or not with concurrent thyroiditis. METHODS: We studied 346 patients with differentiated thyroid carcinomas, comprising 292 papillary carcinomas and 54 follicular carcinomas, who were followed up for 12-298 months (mean 76.10¡68.23 months) according to a standard protocol. We genotyped 200 patients and 144 control individuals for the interleukin-18 +105A/C polymorphism, and we genotyped 183 patients and 137 controls for the interleukin-10 -1082A/G polymorphism. RESULTS: Interleukin-18 polymorphisms were not associated with chronic lymphocytic thyroiditis or any clinical or pathological feature of tumor aggressiveness. However, there was an association between the presence of interleukin-10 variants and chronic lymphocytic thyroiditis. Chronic lymphocytic thyroiditis was present in 21.74% of differentiated thyroid carcinoma patients, most frequently affecting women previously diagnosed with Hashimoto's thyroiditis who had received a lower 131I cumulative dose and did not present lymph node metastases. CONCLUSIONS: We conclude that the inheritance of a G allele at the interleukin-10 -1082A/G polymorphism may favor a concurrent thyroid autoimmunity in differentiated thyroid carcinoma patients, and this autoimmunity may favor a better prognosis for these patients. © 2011 CLINICS.66712031208Pisanu, A., Piu, S., Cois, A., Uccheddu, A., Coexisting Hashimoto's thyroiditis with differentiated thyroid cancer and benign thyroid diseases: Indications for thyroidectomy (2003) Chir Ital, 55, pp. 365-372Segal, K., Ben-Bassat, M., Avraham, A., Har-El, G., Sidi, J., Hashimoto's thyroiditis and carcinoma of the thyroid gland (1985) Int Surg, 70, pp. 205-209Loh, K.C., Greenspan, F.S., Dong, F., Miller, T.R., Yeo, P.P., Influence of lymphocytic thyroiditis on the prognostic outcome of patients with papillary thyroid carcinoma (1999) J Clin Endocrinol Metab, 84, pp. 458-463. , doi: 10.1210/jc.84.2.458Ugolini, C., Basolo, F., Proietti, A., Vitti, P., Elisei, R., Miccoli, P., Lymphocyte and immature dendritic cell infiltrates in differentiated, poorly differentiated, and undifferentiated thyroid carcinoma (2007) Thyroid, 17, pp. 389-393. , doi: 10.1089/thy.2006.0306Arif, S., Blanes, A., Diaz-Cano, S.J., Hashimoto's thyroiditis shares features with early papillary thyroid carcinoma (2002) Histopathology, 41, pp. 357-362. , doi: 10.1046/j.1365-2559.2002.01467.xGasbarri, A., Sciacchitano, S., Marasco, A., Papotti, M., Di Napoli, A., Marzullo, A., Detection and molecular characterisation of thyroid cancer precursor lesions in a specific subset of Hashimoto's thyroiditis (2004) Br J Cancer, 1, pp. 1096-1104Coussens, L.M., Werb, Z., Inflammation and cancer (2002) Nature, 420, pp. 860-867. , doi: 10.1038/nature01322Borrello, M.G., Alberti, L., Fischer, A., Degl'innocenti, D., Ferrario, C., Gariboldi, M., Induction of a proinflammatory program in normal human thyrocytes by the RET/PTC1 oncogene (2005) Proc Natl Acad Sci U S A, 102, pp. 14825-14830. , doi: 10.1073/pnas.0503039102Guarino, V., Castellone, M.D., Avilla, E., Melillo, R.M., Thyroid cancer and inflammation (2009) Mol Cell Endocrinol, 321, pp. 94-102. , doi: 10.1016/j.mce. 2009.10.003Okamura, H., Tsutsi, H., Komatsu, T., Yutsudo, M., Hakura, A., Tanimoto, T., Cloning of a new cytokine that induces IFN-gamma production by T cells (1995) Nature, 378, pp. 88-91. , doi: 10.1038/378088a0Micallef, M.J., Ohtsuki, T., Kohno, K., Tanabe, F., Ushio, S., Namba, M., Interferon-gamma-inducing factor enhances T helper 1 cytokine production by stimulated human T cells: Synergism with interleukin-12 for interferon-gamma production (1996) Eur J Immunol, 26, pp. 1647-1651. , doi: 10. 1002/eji.1830260736Boniotto, M., Segat, L., Milanese, M., Crovella, S., Detection of two functional polymorphisms in the promoter region of the IL-18 gene by single-tube allele specific PCR and melting temperature analysis (2005) J Immunol Methods, 304, pp. 184-188. , doi: 10.1016/j.jim.2005.06.016Arimitsu, J., Hirano, T., Higa, S., Kawai, M., Naka, T., Ogata, A., IL-18 gene polymorphisms affect IL-18 production capability by monocytes (2006) Biochem Biophys Res Commun, 342, pp. 1413-1416. , doi: 10.1016/j.bbrc. 2006.02.096de la Vega, J.R., Vilaplana, J.C., Biro, A., Hammond, L., Bottazzo, G.F., Mirakian, R., IL-10 expression in thyroid glands: Protective or harmful role against thyroid autoimmunity? (1998) Clin Exp Immunol, 113, pp. 126-135. , doi: 10.1046/ j.1365-2249.1998.00628.xLi, M.O., Flavell, R.A., Contextual regulation of inflammation: A duet by transforming growth factor-beta and interleukin-10 (2008) Immunity, 28, pp. 468-476. , doi: 10.1016/j.immuni.2008.03.003Todaro, M., Zerilli, M., Ricci-Vitiani, L., Bini, M., Alea, M.P., Florena, A.M., Autocrine production of interleukin-4 and interleukin-10 is required for survival and growth of thyroid cancer cells (2006) Cancer Res, 66, pp. 1491-1499. , doi: 10.1158/0008-5472.CAN-05-2514Lim, S., Crawley, E., Woo, P., Barnes, P.J., Haplotype associated with low interleukin-10 production in patients with severe asthma (1998) Lancet, 352, p. 113. , doi: 10.1016/S0140-6736(98)85018-6Cooper, D.S., Doherty, G.M., Haugen, B.R., Kloos, R.T., Lee, S.L., Mandel, S.J., Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer (2009) Thyroid, 19, pp. 1167-1214. , doi: 10.1089/thy.2009.0110Pitoia, F., Ward, L., Wohllk, N., Friguglietti, C., Tomimori, E., Gauna, A., Recommendations of the Latin American Thyroid Society on diagnosis and management of differentiated thyroid cancer (2009) Arq Bras Endocrinol Metabol, 53, pp. 884-887. , doi: 10.1590/S0004-27302009000700014Wogensen, L., Huang, X., Sarvetnick, N., Leukocyte extravasation into the pancreatic tissue in transgenic mice expressing interleukin 10 in the islets of Langerhans (1993) J Exp Med, 178, pp. 175-185. , doi: 10.1084/jem.178.1.175Erdogan, M., Karadeniz, M., Ozbek, M., Ozgen, A.G., Berdeli, A., Interleukin-10 gene polymorphism in patients with papillary thyroid cancer in Turkish population (2008) J Endocrinol Invest, 31, pp. 750-754Zabaleta, J., Lin, H.Y., Sierra, R.A., Hall, M.C., Clark, P.E., Sartor, O.A., Interactions of cytokine gene polymorphisms in prostate cancer risk (2008) Carcinogenesis, 29, pp. 573-578. , doi: 10.1093/carcin/bgm277Yao, J.G., Gao, L.B., Liu, Y.G., Li, J., Pang, G.F., Genetic variation in interleukin-10 gene and risk of oral cancer (2008) Clin Chim Acta, 388, pp. 84-88. , doi: 10. 1016/j.cca.2007.10.012Bogunia-Kubik, K., Mazur, G., Wrobel, T., Kuliczkowski, K., Lange, A., Interleukin-10 gene polymorphisms influence the clinical course of non-Hodgkin's lymphoma (2008) Tissue Antigens, 71, pp. 146-150. , doi: 10.1111/j. 1399-0039.2007.00984.xSouza, S.L., Montalli Da Assumpcao, L.V., Ward, L.S., Impact of previous thyroid autoimmune diseases on prognosis of patients with welldifferentiated thyroid cancer (2003) Thyroid, 13, pp. 491-495. , doi: 10.1089/ 105072503322021160Kim, E.Y., Kim, W.G., Kim, W.B., Kim, T.Y., Kim, J.M., Ryu, J.S., Coexistence of chronic lymphocytic thyroiditis is associated with lower recurrence rates in patients with papillary thyroid carcinoma (2009) Clin Endocrinol (Oxf), 71, pp. 581-586. , doi: 10.1111/j.1365-2265.2009.03537.xGupta, S., Patel, A., Folstad, A., Fenton, C., Dinauer, C.A., Tuttle, R.M., Infiltration of differentiated thyroid carcinoma by proliferating lymphocytes is associated with improved disease-free survival for children and young adults (2001) J Clin Endocrinol Metab, 86, pp. 1346-1354. , doi: 10.1210/jc. 86.3.1346Schaffler, A., Palitzsch, K.D., Seiffarth, C., Hohne, H.M., Riedhammer, F.J., Hofstadter, F., Coexistent thyroiditis is associated with lower tumour stage in thyroid carcinoma (1998) Eur J Clin Invest, 28, pp. 838-844. , doi: 10. 1046/j.1365-2362.1998.00363.xSingh, B., Shaha, A.R., Trivedi, H., Carew, J.F., Poluri, A., Shah, J.P., Coexistent Hashimoto's thyroiditis with papillary thyroid carcinoma: Impact on presentation, management, and outcome (1999) Surgery, 126, pp. 1070-1076. , doi: 10.1067/msy.2099.101431Ramos, A.M., Ade, O.S., Barbalho de Mello, L.E., Cirino de Andrade, M., Paiva, F.P., Ramos, C.C., Absence of peritumoral fibrosis or inflammatory infiltrate may be related to clinical progression of papillary thyroid microcarcinoma (2009) Int J Surg Pathol, 17, pp. 432-437. , doi: 10.1177/ 1066896909333749Ozaki, O., Ito, K., Kobayashi, K., Toshima, K., Iwasaki, H., Yashiro, T., Thyroid carcinoma in Graves' disease (1990) World J Surg, 14, pp. 437-440. , doi: 10.1007/ BF01658550Pellegriti, G., Belfiore, A., Giuffrida, D., Lupo, L., Vigneri, R., Outcome of differentiated thyroid cancer in Graves' patients (1998) J Clin Endocrinol Metab, 83, pp. 2805-2809. , doi: 10.1210/jc.83.8.2805Matsubayashi, S., Kawai, K., Matsumoto, Y., Mukuta, T., Morita, T., Hirai, K., The correlation between papillary thyroid carcinoma and lymphocytic infiltration in the thyroid gland (1995) J Clin Endocrinol Metab, 80, pp. 3421-3424. , doi: 10.1210/jc.80.12.3421Yano, Y., Shibuya, H., Kitagawa, W., Nagahama, M., Sugino, K., Ito, K., Recent outcome of Graves' disease patients with papillary thyroid cancer (2007) Eur J Endocrinol, 157, pp. 325-329. , doi: 10.1530/EJE-07-0136Kebebew, E., Treseler, P.A., Ituarte, P.H., Clark, O.H., Coexisting chronic lymphocytic thyroiditis and papillary thyroid cancer revisited (2001) World J Surg, 25, pp. 632-637. , doi: 10.1007/s002680020165